John Patrick Jr Shannon
CIK 1553595 · See Remarks · last filed 2026-02-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.68M
Companies
2
Total Filings
28
Lifetime Open-Market Net
$104.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | See Remarks | 3,046,328 | $6.79 | $20.68M | $63.5K | 24 | 2026-02-02 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Chief Commercial Officer | 0 | — | — | $41.2K | 3 | 2014-11-18 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-05 | XERS | Grant (A) | +250,000 | $0 | EDGAR |
| 2021-11-12 | XERS | Buy (P) | +100,000 | $209.5K | EDGAR |
| 2021-10-05 | — | Grant (A) | +263,829 | $0 | |
| 2021-10-05 | XERS | Disp (D) | −263,829 | $0 | EDGAR |
| 2021-02-01 | XERS | Grant (A) | +150,000 | $0 | EDGAR |
| 2020-08-20 | XERS | Grant (A) | — | $0 | EDGAR |
| 2020-07-15 | XERS | Grant (A) | +3,731 | $8.4K | EDGAR |
| 2020-05-14 | XERS | Buy (P) | +22,000 | $78.0K | EDGAR |
| 2020-05-11 | XERS | Buy (P) | +7,886 | $25.2K | EDGAR |
| 2020-03-02 | XERS | Grant (A) | +65,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.